Abstract
Anti-IgE treatment of intermittent to mild-persistent asthma in a cohort of seven volunteers resulted in improved allergen-induced airway hyperreactivity and a significant reduction in the number of airway myeloid dendritic cells.
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Antibodies, Anti-Idiotypic / therapeutic use*
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Asthma / drug therapy*
-
Asthma / immunology
-
Bronchi* / cytology
-
Bronchi* / immunology
-
Bronchoalveolar Lavage Fluid / cytology
-
Bronchoalveolar Lavage Fluid / immunology
-
Dendritic Cells* / cytology
-
Dendritic Cells* / immunology
-
Female
-
Humans
-
Male
-
Myeloid Cells* / cytology
-
Myeloid Cells* / immunology
-
Omalizumab
-
Treatment Outcome
Substances
-
Antibodies, Anti-Idiotypic
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
anti-IgE antibodies
-
Omalizumab